Underdog Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Underdog Pharmaceuticals is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Its products are based on novel derivatives of a well-known, safe compound, and a new way of looking at cardiovascular disease created through a SENS Research Foundation program.
Underdog Pharmaceuticals has raised $10.0M across 1 funding round on record, the most recent a Seed of $10.0M announced in Sep 2021.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Underdog Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Underdog Pharmaceuticals Funding Rounds
Underdog Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Underdog Pharmaceuticals Funding Compared to Other Health Care Startups
Underdog Pharmaceuticals' latest round of $10.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Underdog Pharmaceuticals in Health Care and Mountain View
Companies Similar to Underdog Pharmaceuticals
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Underdog Pharmaceuticals Funding FAQs
What does Underdog Pharmaceuticals do?
Underdog Pharmaceuticals is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Its products are based on novel derivatives of a well-known, safe compound, and a new way of looking at cardiovascular disease created through a SENS Research Foundation program.
How much funding has Underdog Pharmaceuticals raised?
Underdog Pharmaceuticals has raised $10.0M across 1 round on record. The most recent is a Seed of $10.0M announced in Sep 2021.
When did Underdog Pharmaceuticals last raise funding?
Underdog Pharmaceuticals' most recent funding round on record is a Seed of $10.0M, announced in Sep 2021.
Who is the CEO of Underdog Pharmaceuticals?
Michael Kope is listed as CEO at Underdog Pharmaceuticals.
Where is Underdog Pharmaceuticals headquartered?
Underdog Pharmaceuticals is based in Mountain View, California, United States.
How many employees does Underdog Pharmaceuticals have?
Underdog Pharmaceuticals is in the 11-50 employee band.
How does Underdog Pharmaceuticals' funding compare to other Health Care startups?
Underdog Pharmaceuticals' latest round of $10.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Underdog Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Underdog Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.